Trial
NCT04789655
Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Celgene
Collaborators
—
Condition
Leukemia, Myeloid
Intervention
CC-96191
Why stopped
Business objectives have changed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-31